Litcius/Paper detail

Metformin improves nonalcoholic fatty liver disease in db/db mice by inhibiting ferroptosis

Teng Zhang, Meng‐Yan Wang, Meng-Yan Wang, Qiu-Yue Lv, Yuqian Huang, Peng Zhang, Wen Wang, Yan Zhang, Yaping Bai, Liqun Guo, Yaping Bai, Liqun Guo

2024European Journal of Pharmacology38 citationsDOI

Topics & Concepts

Nonalcoholic fatty liver diseaseGlutathioneReactive oxygen speciesFatty liverHepatocyteLiver diseaseMetforminProgrammed cell deathGPX4Internal medicineLiver injuryEndocrinologyOxidative stressBiologyCancer researchChemistryPharmacologyApoptosisGlutathione peroxidaseMedicineDiabetes mellitusDiseaseCell biologyIn vitroBiochemistryEnzymeCatalaseFerroptosis and cancer prognosisCancer-related molecular mechanisms researchRNA modifications and cancer
Metformin improves nonalcoholic fatty liver disease in db/db mice by inhibiting ferroptosis | Litcius